The closing price of Lineage Cell Therapeutics Inc (AMEX: LCTX) was $1.30 for the day, down -7.80% from the previous closing price of $1.41. On the day, 1044326 shares were traded.
Ratios:
Our analysis of LCTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.14 and its Current Ratio is at 2.14. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on November 02, 2022, initiated with a Outperform rating and assigned the stock a target price of $5.
On June 14, 2022, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $4.
On August 19, 2021, Noble Capital Markets started tracking the stock assigning a Outperform rating and target price of $8.Noble Capital Markets initiated its Outperform rating on August 19, 2021, with a $8 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 08 ’24 when BAILEY DON M bought 96,155 shares for $1.04 per share. The transaction valued at 100,001 led to the insider holds 158,801 shares of the business.
BROADWOOD PARTNERS, L.P. bought 6,730,770 shares of LCTX for $7,000,001 on Feb 06 ’24. The Director now owns 41,666,255 shares after completing the transaction at $1.04 per share. On Dec 29 ’23, another insider, Jayasuriya Anula, who serves as the Director of the company, bought 10,000 shares for $1.09 each. As a result, the insider paid 10,900 and bolstered with 10,000 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 27.38 while its Price-to-Book (P/B) ratio in mrq is 3.59.
Stock Price History:
Over the past 52 weeks, LCTX has reached a high of $1.61, while it has fallen to a 52-week low of $0.84.
Shares Statistics:
A total of 188.53M shares are outstanding, with a floating share count of 187.49M. Insiders hold about 0.55% of the company’s shares, while institutions hold 48.04% stake in the company.
Earnings Estimates
The firm’s stock currently is rated by LCTU analysts. The consensus estimate for the next quarter is $46.57, with high estimates of $3.24 and low estimates of $1.30.
